Avian influenza is defined as the disease caused by infection by the bird flu Type-A virus. These viruses are found commonly in aquatic birds and they can cause infection in domestic poultry and other species of birds. Based on the protein present on the virus surface, the influenza Type-A virus can be sub-classified into neuraminidase (NA) and hemagglutinin (HA). Based on their molecular characteristics and ability to cause disease and mortality in chicken, the avian influenza virus can be classified into highly pathogenic and low pathogenic. However, both are known to spread rapidly in poultry.
MARKET DYNAMICS
The avian influenza vaccines market is driving due to the high demand for poultry for consumption, ongoing research for the development of effective vaccines for disease prevention. Moreover, the growing prevalence of diseases, primarily in developing regions, is a major cause of over 90% of mortality in poultry.
MARKET SCOPE
The "Avian influenza vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of avian influenza vaccines market with detailed market segmentation by vaccine type, stain, and application. The avian influenza vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in avian influenza vaccines market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The avian influenza vaccines market is segmented on the basis of vaccine type, strain and application. Based on vaccine type, the market is segmented as inactivated vaccines, live recombinant vaccines, and combination vaccines. On the basis of strain, the market is categorized as H5 strain, H7 strain, and H9 strain. On the basis of application, the market is categorized as chicken, duck & goose, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the avian influenza vaccines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The avian influenza vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting avian influenza vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the avian influenza vaccines market in these regions.
MARKET PLAYERS
The report covers key developments in the avian influenza vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from avian influenza vaccines market are anticipated to have lucrative growth opportunities in the future with the rising demand for avian influenza vaccines in the global market. Below mentioned is the list of few companies engaged in the avian influenza vaccines market.
The report also includes the profiles of key players in avian influenza vaccines market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boehringer Ingelheim GmbH
- CAVAC
- CEVA
- DHN
- Elanco
- FATRO S.p.A.
- Harbin Veterinary Research Institute (HVRI)
- Merck Animal Health (a subsidiary of Merck & Co. Inc.)
- Merial (a Sanofi Company)
- QianYuanHao Biological Corporation Limited
- Ringpu Biology
- The Qingdao Yebio Biological Engineering Co., Ltd.,
- Zoetis, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.